Thus, among the many activators of LIMK, members of the Rho family of small GTPases (Rho, Rac, and Cdc42) and their effectors (ROCK, PAK, and MK2) are implicated in the progression of various human cancers to invasive and metastatic stages [62]. Here, LIMK1 is linked to cancer.